The reported statements, read against the company's own industry.
Financials view
Market Capitalization
512.16MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue (TTM)
2.10BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Profit Margin
-24.08%
vs Health Information Services peers
Updated Oct 27, 2026
Beta
1.02x
vs all stocks
Updated Oct 27, 2026
52-Week Change
-38.87%
vs all stocks
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Market Capitalization
512.16MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Enterprise Value
1.40BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Forward P/E
11.89x
vs Health Information Services peers
Updated Oct 27, 2026
Price to Sales (TTM)
0.2588x
vs Health Information Services peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.24×.Updated Oct 27, 2026
Price to Book (MRQ)
1.41x
vs Health Information Services peers
Updated Oct 27, 2026
Enterprise to Revenue
0.6660x
vs Health Information Services peers
Updated Oct 27, 2026
Enterprise to EBITDA
22.89x
vs Health Information Services peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 20.79×.Updated Oct 27, 2026
Gross Margin
12.39%
vs Health Information Services peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 17.25%.Updated Oct 27, 2026
Profit Margin
-24.08%
vs Health Information Services peers
Updated Oct 27, 2026
Operating Margin
-1.34%
vs Health Information Services peers
Updated Oct 27, 2026
Return on Assets (TTM)
-0.78%
vs Health Information Services peers
Updated Oct 27, 2026
Return on Equity (TTM)
-66.97%
vs Health Information Services peers
Updated Oct 27, 2026
Revenue (TTM)
2.10BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue per Share (TTM)
18.64USDUpdated Oct 27, 2026
Quarterly Revenue Growth
46.90%
vs Health Information Services peers
Updated Oct 27, 2026
Gross Profit (TTM)
361.64MUSD
vs all stocks (USD)
Updated Oct 27, 2026
EBITDA (TTM)
67.22MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Net Income (TTM)
-511.06MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Operating Cash Flow (TTM)
54.32MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Levered Free Cash Flow (TTM)
126.85MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 27, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Payout Ratio
0.00%
vs Health Information Services peers
Updated Oct 27, 2026
Revenue
1.88BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
1.48BUSDFY2025 · Dec 31, 2025
Gross Profit
399.88MUSDFY2025 · Dec 31, 2025
Operating Income
-19.83MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-534.64MUSDFY2025 · Dec 31, 2025
Income Tax Expense
-126.00KUSDFY2025 · Dec 31, 2025
Net Income
-534.51MUSDFY2025 · Dec 31, 2025
EBIT
-477.17MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
85.02MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
303.87MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
4.19MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
57.47MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-5.07USDFY2025 · Dec 31, 2025
EPS (Diluted)
-5.07USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
114.21MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
114.21MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-534.51MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-425.17MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
180.70MUSDFY2025 · Dec 31, 2025
Interest Paid
41.16MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-534.51MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
115.85MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-2.18MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
39.74MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
38.53MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
73.70MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
6.64MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-162.94MUSDFY2025 · Dec 31, 2025
Net Intangibles (CF)
-34.09MUSDFY2025 · Dec 31, 2025
Net Acquisitions
-14.00KUSDFY2025 · Dec 31, 2025
Other Investing Activity
-57.44MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-57.46MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
408.05MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-342.98MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-40.00MUSDFY2025 · Dec 31, 2025
Common Dividends Paid
-11.13MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-49.86MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-35.92MUSDFY2025 · Dec 31, 2025
Shares Outstanding
112.68MSharesUpdated Oct 27, 2026
Float Shares
94.23MSharesUpdated Oct 27, 2026
Shares Short
12.91MSharesUpdated Oct 27, 2026
Short Ratio
5.39days
vs all stocks
Updated Oct 27, 2026
Short % of Shares Outstanding
11.55%
vs all stocks
Updated Oct 27, 2026
% Held by Insiders
3.10%
vs all stocks
Updated Oct 27, 2026
% Held by Institutions
101.59%
vs all stocks
Updated Oct 27, 2026
Total Cash (MRQ)
115.70MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Cash per Share (MRQ)
1.02USDUpdated Oct 27, 2026
Total Debt (MRQ)
970.43MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Debt to Equity (MRQ)
2.53x
vs Health Information Services peers
Updated Oct 27, 2026
Current Ratio (MRQ)
1.24x
vs Health Information Services peers
Updated Oct 27, 2026
Book Value per Share (MRQ)
3.40USDUpdated Oct 27, 2026
Total Assets
1.90BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
506.37MUSDFY2025 · Dec 31, 2025
Total Liabilities
1.48BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
1.39BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.10BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
385.26MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
151.86MUSDFY2025 · Dec 31, 2025
Accounts Receivable
309.86MUSDFY2025 · Dec 31, 2025
Accounts Payable
59.78MUSDFY2025 · Dec 31, 2025
Short-term Debt
15.34MUSDFY2025 · Dec 31, 2025
Deferred Revenue
1.20MUSDFY2025 · Dec 31, 2025
Long-term Debt
974.36MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
8.01MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
1.18MUSDFY2025 · Dec 31, 2025
Retained Earnings
-1.32BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
415.19MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
61.43MUSDFY2025 · Dec 31, 2025
52-Week Low
2.10USDUpdated Oct 27, 2026
52-Week High
7.66USDUpdated Oct 27, 2026
52-Week Change
-38.87%
vs all stocks
Updated Oct 27, 2026
Beta
1.02x
vs all stocks
Updated Oct 27, 2026
50-Day MA
4.22USDUpdated Oct 27, 2026
200-Day MA
3.86USDUpdated Oct 27, 2026
Avg 10-Day Volume
1.88MSharesUpdated Oct 27, 2026
Avg 30-Day Volume
2.23MSharesUpdated Oct 27, 2026
Diluted EPS (TTM)
-4.49USDUpdated Oct 27, 2026
Other Income / Expense
-461.52MUSDFY2025 · Dec 31, 2025
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 12.4%, lower than 95% of its Health Information Services peers (median 61.2%)Significant
Within or Near the Altman Distress ZoneUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedElevated Leverage on Three Denominators
Within or Near the Altman Distress ZoneUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedElevated Leverage on Three Denominators
Within or Near the Altman Distress ZoneUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedElevated Leverage on Three Denominators